Clinical Trial Update: Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating four weeks of omeprazole treatment for non-erosive reflux disease in Japanese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-erosive Reflux Disease

Drugs mentioned

• Omeprazole (Omeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Non-erosive Reflux Disease | Phase 3 | Status: COMPLETED